Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse

  1. Dimopoulos, M.
  2. Weisel, K.
  3. Moreau, P.
  4. Anderson, L.D.
  5. White, D.
  6. San-Miguel, J.
  7. Sonneveld, P.
  8. Engelhardt, M.
  9. Jenner, M.
  10. Corso, A.
  11. Dürig, J.
  12. Pavic, M.
  13. Salomo, M.
  14. Casal, E.
  15. Srinivasan, S.
  16. Yu, X.
  17. Nguyen, T.V.
  18. Biyukov, T.
  19. Peluso, T.
  20. Richardson, P.
Revue:
Leukemia

ISSN: 1476-5551,  0887-6924

Année de publication: 2021

Volumen: 35

Número: 6

Pages: 1722-1731

Type: Article

DOI: 10.1038/S41375-020-01021-3 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus